ArticleScientific reports2026
Aerodynamic barriers to inhaled furosemide delivery during dyspnoea revealed by experimental and computational modelling.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inhaled furosemide shows potential for relieving refractory dyspnoea, yet clinical trials have yielded inconsistent results. We hypothesise this failure stems from a "Dyspnoea Paradox", where high inspiratory flows create an aerodynamic barrier. We evaluated furosemide delivery using a vibrating mesh nebuliser under simulated dyspnoeic conditions (tidal volume 1.39 L, frequency 28.6 min⁻¹). The study integrated standard Pharmacopoeial characterisation, in vitro deposition in a realistic human airway replica, and computational modelling (Large Eddy Simulation and Multiple-Path Particle Dosimetry). While standard tests indicated optimal aerodynamic properties (MMAD 3.03 μm), realistic modelling revealed a critical barrier. Both experimental and computational results showed excessive deposition in the upper parts of the airways, caused by a "Laryngeal Jet" that increases inertial impaction and turbulent dispersion. Standard Pharmacopoeial methods thus yield false-positive predictions of delivery efficiency for dyspnoeic patients. We propose a mechanistic hypothesis that rapid inhalation associated with air hunger filters out a significant portion of the therapeutic dose before it reaches the target tracheobronchial receptors, which may partially explain the inconsistent clinical outcomes. Clinical strategies must therefore shift from dose escalation to flow-governed delivery or shape-optimised carriers to overcome this aerodynamic filtration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.